Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

McMaster University

$47,000.00

Microsystems for drug discovery and biological studies

FY 2019-20

Summary
Miniaturization of assays in genomics and proteomics led to dramatic improvements in their speed at significantly lower cost, facilitating an explosion in their use in a wide variety of applications. For instance, sequencing a genome costs 10,000$ today as opposed to 100 million$ a decade ago; this has revolutionized many branches of biological research, drug discovery and clinical diagnostics.*** The next grand challenge in miniaturization of laboratory automation technologies is in handling and manipulating of living biological cells, embryos, larvae and small organisms that would confer the same advantages of speed, cost, accuracy and scale over existing methods. These scalable technologies are critically important in understanding disease process and in drug discovery where model organisms such as Drosophila (fly), C.elegans (worm) and artificial tissue constructs that mimic the natural organization of cells in an organ are being used. For instance, the recently announced Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative, to develop technologies to revolutionize our understanding of the organizational principles of the human brain, targets Drosophila and C.elegans for tool developmnt in its first 5 years. *** My laboratory has recently emerged at the forefront of this nascent field due our established work on the electrically stimulated behavior of C.elegans worms and our more recent findings on the neuronal response of Drosophila larva to auditory stimulus. Also, our recent efforts at adapting the rapidly emerging 3D printing technology to print vascular networks in gels provides a novel way to position cells in specific patterns in 3D to engineer tissue like constructs for biological experimentation.*** Building on our established work and recent successes, the short-term aim of this research program, is to investigate and understand the fundamental science behind interaction of external stimuli such as electric field, sound or flow with biological living organisms such as C.elegans worms and Drosophila larva. Using that understanding, we will design and engineer innovative Lab-on-Chip devices for biological and drug discovery assays that involve these organisms. We will also develop hybrid microfabrication technologies for the manufacture of artificial tissue like constructs with integrated vascular networks to model disease processes and for use in drug discovery.*** Over the long term, we will develop integrated microsystems that lower the cost, increase throughput and automate these assays targeted towards specific applications in drug discovery or biological research. By lowering the cost of research and enhancing capability, these systems can significantly enhance the productivity of biological and biomedical researchers.**
Program
Discovery Grants Program - Individual
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
RGPIN-2015-06540
Name nom
Selvaganapathy, Ponnambalam
Department département
Mechanical Engineering
Organization id
27
Institution établissement
McMaster University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2019
Competition year année de concours
2015
Award amount
47000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1510
Committee name en
Electrical and Computer Engineering
Committee name fr
Génie électrique et informatique
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
1901
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical technology
Research subject fr
Technologie biomédicale
Installment
inst:5 - 6
Partie
5
Nb partie
6
Application title
Microsystems for drug discovery and biological studies
Keyword
NSERC
Application summary
Miniaturization of assays in genomics and proteomics led to dramatic improvements in their speed at significantly lower cost, facilitating an explosion in their use in a wide variety of applications. For instance, sequencing a genome costs 10,000$ today as opposed to 100 million$ a decade ago; this has revolutionized many branches of biological research, drug discovery and clinical diagnostics.*** The next grand challenge in miniaturization of laboratory automation technologies is in handling and manipulating of living biological cells, embryos, larvae and small organisms that would confer the same advantages of speed, cost, accuracy and scale over existing methods. These scalable technologies are critically important in understanding disease process and in drug discovery where model organisms such as Drosophila (fly), C.elegans (worm) and artificial tissue constructs that mimic the natural organization of cells in an organ are being used. For instance, the recently announced Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative, to develop technologies to revolutionize our understanding of the organizational principles of the human brain, targets Drosophila and C.elegans for tool developmnt in its first 5 years. *** My laboratory has recently emerged at the forefront of this nascent field due our established work on the electrically stimulated behavior of C.elegans worms and our more recent findings on the neuronal response of Drosophila larva to auditory stimulus. Also, our recent efforts at adapting the rapidly emerging 3D printing technology to print vascular networks in gels provides a novel way to position cells in specific patterns in 3D to engineer tissue like constructs for biological experimentation.*** Building on our established work and recent successes, the short-term aim of this research program, is to investigate and understand the fundamental science behind interaction of external stimuli such as electric field, sound or flow with biological living organisms such as C.elegans worms and Drosophila larva. Using that understanding, we will design and engineer innovative Lab-on-Chip devices for biological and drug discovery assays that involve these organisms. We will also develop hybrid microfabrication technologies for the manufacture of artificial tissue like constructs with integrated vascular networks to model disease processes and for use in drug discovery.*** Over the long term, we will develop integrated microsystems that lower the cost, increase throughput and automate these assays targeted towards specific applications in drug discovery or biological research. By lowering the cost of research and enhancing capability, these systems can significantly enhance the productivity of biological and biomedical researchers.**